Treatment Preferences and Prognosis of Acute Traumatic Brain Injury; Outcomes in the Patients who were on Antiplatelet Therapy

Dr. Hasan Emre Aydin MD, PhD

Authors

Dr. Hasan Emre Aydin MD, PhD

Keywords:

Abstract

Introduction-Antiplatelet therapy comprises a group of drugs used in the treatment of valvular heart disease, cardiac stents, rhythm disorders, pulmonary embolism and cerebrovascular diseases (1). The patients followed-up by regular measurement of the haemostatic parameters usually miss their follow-up visits due to the social reasons and are exposed to uncontrolled side effects of these drugs. The people admitting for the side effects of anticoagulant therapy are commonly seen in the emergency department because of the increased use of this group of drugs (2,3).

Downloads

How to Cite

Treatment Preferences and Prognosis of Acute Traumatic Brain Injury; Outcomes in the Patients who were on Antiplatelet Therapy. (2015). Global Journal of Medical Research, 15(9), 21-25. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

Author Biography

Dr. Hasan Emre Aydin MD, PhD

Hasan Emre Aydin is an academic author and reviewer affiliated currently with Uni Research (Norway) and Sağlık Bilimleri Üniversitesi (Turkey) as well as Ankara Onkoloji Eğitim ve Araştırma Hastanesi (Turkey). He has worked at multiple health and medical institutions, including the Ministry of Health in Turkey and various hospitals and universities. He has contributed to research areas including spinal cord injury research, MRI in cancer diagnosis, prostate cancer diagnosis and treatment, and radiomics and machine learning in medical imaging.

References

Eruyar E, Guney F (2011) Prognosis In Anticoagulant Theraphy Related Intracerebral Hemorrhage. 17(3), 101-104.

Christopher Beynon, Daniel Hertle, Andreas Unterberg, Oliver Sakowitz (2012) Clinical review: Traumatic brain injury in patients receiving antiplatelet medication. 16(4), 228. https://doi.org/10.1186/cc11292

Bleumink Visser Le, Vulto Trienekens Ph, Hofman A (2004) The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants. 127(1), 85-89. https://doi.org/10.1111/j.1365-2141.2004.05162.x

Thompson Hj, Mccormick Wc, Kagan Sh (2006) Traumatic Brain Injury In Older Adults: Epidemiology, Outcomes, And Future Implications. 54(10), 1590-1595.

Franke Cl, De Jonge, J., Wieten Jc, Coul Aww, J. Gijn (2009) Intracerebral Hematomas During Anticoagulant Treatment. 21, 726-730.

Zuckerman Sl, Morgan Cd, S. Burks, Forbes Ja, Chambless Lb, Et Al (2014) Functional And Structural Traumatic Brain Injury In Equestrian Sports: A Review Of The Literature. https://doi.org/10.1016/J.Wneu

Shen X, Dutcher Sk, Palmer J, Liu X, Kiptanui Z (2014) A Systematic Review Of The Benefits And Risks Of Anticoagulation Following Traumatic Brain Injury.

Wj Bommer (2012) Current and Future Alternatives to Warfarin for the Prevention of Stroke in Atrial Fibrillation. 11(2), 45-54. https://doi.org/10.1097/hpc.0b013e31824d705a

Le Roux, P., Pollack Cv, M. Milan, A. Schaefer (2014) Race Against The Clock: Overcoming Challenges In The Management of Anticoagulant Associated Intrac - erebral Hemorrhage. 1-20.

Asvaldsdottir Sorensen B, Onundarson Gudmundsdottir Br (2009) The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery. 124(6), 695-700. https://doi.org/10.1016/j.thromres.2009.08.008

Anderson Cs (2009) Medical Management Of Acute Intracerebral Hemorrhage. 15(2), 93-98.

Pfeilschifter W, Spitzer D, Czech-Zechmeister B, Steinmetz H, Foerch C (2011) Increased Risk Of Hemorrhagic Transformation In Ischemic Stroke Occurring During Warfarin Anticoagulation: An Experimental Study In Mice. 42(4), 1116-1121.

Siegmund Hu, R. Burghaus, D. Kubitza, K. Coboeken (2014) Contribution Of Rivaroxaban To The International Normalized Ratio When Switching To Warfarin For Anticoagulation As Determined By Simulation Studies. https://doi.org/10.1111/Bcp.12571

Aldemir A, Avsar F, Comoglu S (2011) A Case Of Warfarin Associated Intracerebral Hemorrhage With Delayed Presentation Of Radiological Findings. 17(3), 107-110.

Hart Rg, Boop Bs, Anderson Dc (1995) Oral Anticoagulans And Intracranial Hemorrhage: Facts And Hypotheses. 26, 1471-1477.

Lavoie A, Ratte S, Clas D, Demers J, Moore L (2004) Preinjury Warfarin Use Among Elderly Patients With Closed Head Injuries in a Trauma Center. 56(4), 802-807.

M. Eroglu, U. Ozturk, Yuceturk Cn, M. Ciftci, S. Murat, Et Al (2005) The Relationship Between Inr Level And Microscopic Hematuria In Anticoagulant Patients. 31(4), 574-579.

Duncan Jm, Cooley Da, Reul Gj, Ott Da, Hallman Gl, Et Al (1986) Durability And Low Thrombogenicity Of The St. Jude Medical Valve At 5 Follow Up. 42, 500-505.

Parra Mw, L. Zucker, Johnson Es, D. Gullett, C. Avila, Et Al (2013) Dabigatran Bleed Risk With Closed Head Injuries: Are We Prepared?. 119(3), 760-765.

Gray Diamod T, Fannin Chee Cp (1988) Subdural Haematoma Associated with Long term Oral Anticoagulation. 2, 351-356.

Wassef Sn, Abel Tj, A. Grossbach, Viljoen Sv, Jackson Aw, Et Al (2013) Traumatic Intracranial Hemorrhage In Patients Taking Dabigatran: Report Of 3 Cases And Review Of The Literature. 73(2), 363-378.

Langlois Rutland-Brown W, Xi Thomas Ke (2006) Incidence Of Traumatic Brain Injury In The United States, 2003. 21(6), 544-8.

Yılmaz M, Demirci S (2011) The factors affecting mortality in patients with intracerebral hemorrhage. 2(4), 404-407.